Simcha Therapeutics is a biopharmaceutical company developing an engineered cytokine immunotherapy for cancer. Founded by Aaron Ring in 2018, Simcha Therapeutics is backed by investors that include Connecticut Innovations, Sequoia Capital China, and Wuxi Venture Capital Group and is headquartered in New Haven.